Critical Diagnostics Recalls Presage ST2 Assay Kits Due to Inaccurate Results
Critical Diagnostics is recalling Presage ST2 Assay kits because they may produce inaccurate test results for patients with chronic heart failure.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The hazard is limited to inaccurate diagnostic data rather than direct physical injury.
Plain-English summary
Critical Diagnostics is recalling 33 units of the Presage ST2 Assay, catalog numbers BC-1065 and BC-1065E. This in vitro diagnostic device is used to measure ST2 levels in serum or plasma to help assess the prognosis of patients diagnosed with chronic heart failure.
The recall was initiated because the manufacturer confirmed that it is possible to obtain inaccurate test results when using these specific kits. The affected lots include Lot No. RN-43116-4 for US distribution and Lots RN-42467-1, RN-42467-2, RN-43116-1, RN-43116-2, and RN-43116-3 for European distribution.
The products were distributed in the United States, including California, as well as in Austria, Spain, the United Kingdom, and Italy. Users of these kits should stop using the affected lots and contact Critical Diagnostics for further instructions.
The recalled product
- Product
- Presage ST2 Assay, catalog numbers BC-1065 and BC-1065E. The Critical Diagnostics Presage ST2 Assay kit is an in vitro diagnostic device that quantitatively measures ST2 in serum or plasma by enzyme-linked immunosorbent assay (ELISA) in a microtiter plate format. The Presage S
- Manufacturer
- Critical Diagnostics
- Hazard
- Affected units
- 33
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- RN-42467-2
- RN-43116-1
- RN-43116-2
- RN-43116-3.
Distribution
Distributed in 1 state:
Related recalls
Same hazard · inaccurate results
See all →- HighHealthmark Protein Test Recalled Due to Expired Ingredient
FDA (Devices) · 2026-09-02
- HighHardyDisk AST Cefiderocol 30µg for In Vitro Testing Recalled Due to Incorrect Cartridges
FDA (Devices) · 2026-08-12
- HighGEM Premier 7000 with iQM3 Blood Analysis Systems Recalled for Solution Concentration Issues
FDA (Devices) · 2026-08-12
- Highepoc BGEM BUN Test Card for epoc Blood Analysis System
FDA (Devices) · 2026-05-06
- HighAbbott i-STAT EG7+ Blood Gas Cartridges Reporting Inaccurate Results
FDA (Devices) · 2026-05-06